Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03646396
What this trial is testing

Effect of Sofosbuvir-daclatasuvir on Angiogenesis

Who this might be right for
HCV Coinfection
Sherief Abd-Elsalam 40
Testing effectiveness (Phase 2)Study completedNCT00165451
What this trial is testing

A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer

Who this might be right for
Neoplasms
Dana-Farber Cancer Institute 20
Not applicableStudy completedNCT01837160
What this trial is testing

Angiogenesis and Fibrosis in Aortic Stenosis

Who this might be right for
Aortic StenosisFibrosisNeovascularization, Pathologic
University of Edinburgh 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT04807166
What this trial is testing

Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsFallopian Tube NeoplasmsNeoplasms by Site+12 more
Wenjun Cheng 56
Testing effectiveness (Phase 2)Study completedNCT01391962
What this trial is testing

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

Who this might be right for
Sarcoma, Alveolar Soft Part
National Cancer Institute (NCI) 34
Not applicableStudy completedNCT00137488
What this trial is testing

Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)

Who this might be right for
Glioma
AHS Cancer Control Alberta 10
Not applicableUnknownNCT04952688
What this trial is testing

Modifications in Retinal Microvascularization With Targeted Anti-angiogenic Therapy in Colorectal Cancer

Who this might be right for
Colorectal Cancer
Centre Georges Francois Leclerc 30
Not applicableStudy completedNCT00602862
What this trial is testing

Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250

Who this might be right for
Clear Cell Renal Cell Carcinoma
Radboud University Medical Center 26
Large-scale testing (Phase 3)UnknownNCT00143585
What this trial is testing

NOGA Angiogenesis Revascularization Therapy: Evaluation by RadioNuclide Imaging - The Northern Trial

Who this might be right for
Myocardial Ischemia
Unity Health Toronto 120
Not applicableEnded earlyNCT03641287
What this trial is testing

The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors

Who this might be right for
Ovarian CancerFallopian Tube AdenocarcinomaFallopian Tube Carcinosarcoma+19 more
University of Washington 64
Not applicableUnknownNCT02452619
What this trial is testing

MRI Brain Changes Induced by Hyperbaric Oxygen Therapy in Brain Injury Patients

Who this might be right for
Hyperbaric Oxygen TherapyMild Cognitive Impairment
Assaf-Harofeh Medical Center 30
Not applicableStudy completedNCT06286371
What this trial is testing

Pelvic Neuro-Angiogenesis in Deep Endometriosis

Who this might be right for
Endometriosis-related PainEndometriosisDeep Endometriosis+1 more
Uludag University 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06621095
What this trial is testing

Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)

Who this might be right for
Pancreatic CancerFirst-lineMetastatic Pancreatic Cancer
RenJi Hospital 104
Not applicableLooking for participantsNCT07349277
What this trial is testing

Evaluation of sFlt-1/PlGF Ratio ,OPG and sEng as Predictive Biomarkers in the Diagnosis and Treatment Evaluation of Preeclampsia

Who this might be right for
PreeclampsiaGestational HypertensionHypertensive Disorders of Pregnancy
Ammar Jassim Abed 120
Not applicableStudy completedNCT04609332
What this trial is testing

Endothelial Damage and Angiogenesis Biomarkers During COVID-19

Who this might be right for
Covid19AngiogenesisEndothelial Dysfunction+1 more
University of Chile 40
Testing effectiveness (Phase 2)UnknownNCT02748707
What this trial is testing

Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study

Who this might be right for
Oral Squamous Cell CarcinomaCarcinoma of Buccal MucosaTongue Cancers+1 more
Tata Memorial Hospital 64
Large-scale testing (Phase 3)Study completedNCT00387764
What this trial is testing

Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 80
Not applicableUnknownNCT06062563
What this trial is testing

Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer

Who this might be right for
Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
Peking Union Medical College Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT01215565
What this trial is testing

Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma

Who this might be right for
Hepatocellular CarcinomaFibrolamellar Hepatocellular Carcinoma
Assistance Publique - Hôpitaux de Paris 4
Testing effectiveness (Phase 2)UnknownNCT00378638
What this trial is testing

Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study

Who this might be right for
Breast Cancer
Chap, Linnea I., M.D. 30
Next Page